RIMAG GROUP

2522
4.3151.29% ( +0.055 )
Delay Closed: Nov 16, 16:08:00

Overview

RIMAG GROUP (2522)

Jiangxi Rimag Group Co., Ltd., together with its subsidiaries, invests in and operates medical imaging centers in Mainland China, Hong Kong, Macau, and internat...

Open
4.190
High
4.430
Low
4.155
Prev. Close
4.260
Volume
141.00K
Turnover
611.11K
Avg Price
4.334
Bid/Ask Ratio
73.91%
Amplitude
6.46%
52wk High
18.510
Volume Ratio
0.23
Turnover Ratio
0.04%
52wk Low
3.740
HK Mkt Cap
1.48B
Market CapHKD
1.94B
P/ETTM
Loss
P/EDynamic
Loss
P/EStatic
--
EPSTTM
-0.0679
EPSDynamic
-0.0710
EPSStatic
--
BVPS
5.02
P/B
0.86
HK Shares
343.56M
Dividend YieldTTM
--
DividendTTM
--
Shares
450.50M
Min lot size
500
Currency
HKD

RIMAG GROUP Analyst Rating

View more

Forecast & Rating

May 1, 2026
Price forecast
HK$9.00108.57%
Forecast & RatingStrong buy
1analysts
  • Strong buy100.00%
  • Buy0.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Nov, 9

    Rimag Group closed up 2.2% at HK$4.19, shaping a morning spike-and-fade followed by an afternoon recovery: it jumped about 8% to HK$4.435 by 10:01 BJ time, fell back to HK$4.12 at the morning close, then rebounded from HK$4.12 in the afternoon. Volume was only 17,500 shares and HK$73,113 turnover, with a 0.01% turnover rate amplifying the swing, while recent coverage centred on 7%-8% share-price moves rather than any substantive company announcement. Revenue and earnings diverged: Q2 2026 revenue was HK$296.3 million, up 15.79% year on year, but net profit was a HK$8.02 million loss, down 189.05%, with EPS of -HK$0.0208, a PB of 0.83x and a PE of -61.67x. The price remains below its MA20 of HK$4.543 and MA60 of HK$4.87, down 49.46% year to date, 77.36% below its 52-week high of HK$18.51 and 12.03% above its 52-week low of HK$3.74. Still, the afternoon rebound left the stock at HK$4.19, slightly easing near-term selling pressure.

  2. Nov, 6

    After rallying 7% in the previous session, Rimag Group opened at HK$4.20, briefly touched HK$4.34, then faded through the afternoon to close at the day's low of HK$4.10, down 5.6% from HK$4.345, on only 156,500 shares and HK$654,188 of turnover, a 0.05% turnover rate that amplified the pullback. Revenue growth and profitability diverge: Q2 2026 revenue rose 15.79% year on year to HK$296.3 million, yet net profit swung to a HK$8.02 million loss, down 189%, leaving EPS at -HK$0.0208 and ROE at -1.41%. The price sits below both the MA20 of HK$4.58 and MA60 of HK$4.878, is down 50.54% year to date and 77.85% below the 52-week high of HK$18.51, though still 9.63% above the HK$3.74 low, with PB at 0.82x. While trading has stayed thin since the interim report, daily swings remain sensitive to small flows.

  3. Nov, 5

    Rimag Group rebounded from an early dip to close at HK$4.345, up 5.7% from the prior HK$4.110, on turnover of just HK$331,258 and a 0.02% turnover rate, thin volume that magnified the move; the stock spiked to HK$4.395 before consolidating between HK$4.21 and HK$4.35 in the afternoon, echoing the dispersion theme across Hong Kong's leftover small caps. Fundamentals contrast with the price action: Q2 2026 revenue rose 15.79% year on year to HK$296.3 million, yet net profit was a HK$8.02 million loss, down 189% yoy, with a -2.71% net margin and EPS of -HK$0.0208, so top-line growth has not converted into earnings. The price position remains weak: down 47.59% year to date, 76.5% below the 52-week high of HK$18.51 set on 18 November 2025 and only 16.2% above the 52-week low of HK$3.74, closing under both the MA20 of HK$4.621 and MA60 of HK$4.887. PB is 0.87x on a HK$1.96 billion market cap, after a 7.13% shrink-volume pullback the prior week, though turnover under HK$340,000 limits the signal from a single session.

  4. Nov, 3

    Rimag Group opened lower, probed 4.020 HKD in the morning session and rebounded to close at 4.160 HKD, down 3.26% from the previous close of 4.300 HKD, with an intraday range of 4.300/4.020 HKD; a recent roughly 7% and 6% two-session slide and thin trading after the interim report weighed on bids. The operating picture showed revenue growth against wider losses: Q2 2026 revenue rose 15.79% year on year to 296.3 million HKD, while net profit was -8.02 million HKD, down 189.05%, EPS was -0.0208 HKD, net margin -2.71% and operating profit -4.64 million HKD. The stock remains weak on price location, down 49.82% year to date, 77.53% below its 52-week high of 18.51 HKD and only 11.23% above its 52-week low of 3.74 HKD, while sitting below MA20 4.697 and MA60 4.901; PB is 0.830 and market value 1.874 billion HKD. However, turnover was only 563,400 HKD and turnover rate 0.040%, limiting the price signal under thin liquidity.

  5. Oct, 22

    RIMAG Group (2522.HK) opened at its day high of HK$4.810 and closed at HK$4.610, down roughly 4.2% from the prior close, on thin turnover of HK$2.08mn and a 0.13% turnover rate, sliding to HK$4.415 at 13:39 BJ before a modest afternoon recovery. The interim report framed an initial transformation with 'the most difficult moment passing', and Q2 revenue rose 15.8% yoy to HK$296mn, yet net loss reached HK$8.0mn (-189% yoy), EPS -HK$0.0208 and ROE -1.41%, so revenue growth alongside widening losses weighed on the shares. Post-results activity stayed quiet, with weekly swings of -7.13% and +14.89%. At a 0.92x PB and HK$2.08bn market cap, the close sits well below the day's high and near the lower end of its recent range, while medical imaging penetration of about 1% offers long-term space against near-term earnings pressure.

News